Kraig Biocraft Labs Stock Performance
| KBLB Stock | USD 0.08 0 5.00% |
The company secures a Beta (Market Risk) of -0.43, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Kraig Biocraft are expected to decrease at a much lower rate. During the bear market, Kraig Biocraft is likely to outperform the market. At this point, Kraig Biocraft Labs has a negative expected return of -0.16%. Please make sure to verify Kraig Biocraft's potential upside, day median price, and the relationship between the treynor ratio and accumulation distribution , to decide if Kraig Biocraft Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Kraig Biocraft Labs has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors. ...more
| Begin Period Cash Flow | 816.9 K | |
| Total Cashflows From Investing Activities | -547.4 K | |
| Free Cash Flow | -1.9 M |
Kraig |
Kraig Biocraft Relative Risk vs. Return Landscape
If you would invest 10.00 in Kraig Biocraft Labs on December 22, 2024 and sell it today you would lose (1.60) from holding Kraig Biocraft Labs or give up 16.0% of portfolio value over 90 days. Kraig Biocraft Labs is currently does not generate positive expected returns and assumes 5.1498% risk (volatility on return distribution) over the 90 days horizon. In different words, 45% of otc stocks are less volatile than Kraig, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Kraig Biocraft Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kraig Biocraft's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Kraig Biocraft Labs, and traders can use it to determine the average amount a Kraig Biocraft's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.031
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KBLB |
Estimated Market Risk
| 5.15 actual daily | 45 55% of assets are more volatile |
Expected Return
| -0.16 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.03 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Kraig Biocraft is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kraig Biocraft by adding Kraig Biocraft to a well-diversified portfolio.
Kraig Biocraft Fundamentals Growth
Kraig OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Kraig Biocraft, and Kraig Biocraft fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Kraig OTC Stock performance.
| Return On Asset | -0.32 | |||
| Current Valuation | 34.14 M | |||
| Shares Outstanding | 1.02 B | |||
| Price To Earning | (9.37) X | |||
| Price To Sales | 1,199 X | |||
| EBITDA | (2.64 M) | |||
| Cash And Equivalents | 4.82 M | |||
| Total Debt | 95.24 K | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (1.8 M) | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 3.02 M | |||
| Retained Earnings | (22.47 M) | |||
| Current Asset | 356 K | |||
| Current Liabilities | 2.68 M | |||
About Kraig Biocraft Performance
By analyzing Kraig Biocraft's fundamental ratios, stakeholders can gain valuable insights into Kraig Biocraft's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Kraig Biocraft has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Kraig Biocraft has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Kraig Biocraft Laboratories, Inc. engages in developing protein-based fibers using recombinant DNA technology for commercial applications in the technical textile and specialty fiber industries in the United States. The company was incorporated in 2006 and is headquartered in Ann Arbor, Michigan. Kraig Biocraft operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 38 people.Things to note about Kraig Biocraft Labs performance evaluation
Checking the ongoing alerts about Kraig Biocraft for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Kraig Biocraft Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Kraig Biocraft Labs generated a negative expected return over the last 90 days | |
| Kraig Biocraft Labs has high historical volatility and very poor performance | |
| Kraig Biocraft Labs has some characteristics of a very speculative penny stock | |
| Kraig Biocraft Labs currently holds 95.24 K in liabilities. Kraig Biocraft Labs has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Kraig Biocraft until it has trouble settling it off, either with new capital or with free cash flow. So, Kraig Biocraft's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Kraig Biocraft Labs sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Kraig to invest in growth at high rates of return. When we think about Kraig Biocraft's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (8.05 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kraig Biocraft Labs currently holds about 4.82 M in cash with (1.8 M) of positive cash flow from operations. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Kraig Biocraft's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Kraig Biocraft's stock is overvalued or undervalued compared to its peers.
- Examining Kraig Biocraft's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Kraig Biocraft's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Kraig Biocraft's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Kraig Biocraft's otc stock. These opinions can provide insight into Kraig Biocraft's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Kraig OTC Stock analysis
When running Kraig Biocraft's price analysis, check to measure Kraig Biocraft's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kraig Biocraft is operating at the current time. Most of Kraig Biocraft's value examination focuses on studying past and present price action to predict the probability of Kraig Biocraft's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kraig Biocraft's price. Additionally, you may evaluate how the addition of Kraig Biocraft to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |